CERES, a retrospective study of patients with advanced renal cell carcinoma who received cabozantinib as part of the UK Managed Access Program: Baseline characteristics and clinical outcomes

Autor:	B. Szabados, A. Michael, T. Powles, K. Fife, B. Klair, V. Perrot, B. Venugopal
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Diseases of the genitourinary system. Urology RC870-923 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	European Urology Open Science, Vol 21, Iss , Pp S190-S191 (2020)
Druh dokumentu:	article
ISSN:	2666-1683
DOI:	10.1016/S2666-1683(20)36237-6
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/c628179fd06f46fd886f477b37791e7f Zobrazit plný text záznamu View record in DOAJ